Genetics of Reproductive Aging from Gonadal Dysgenesis through Menopause

Swapna Desai; Aleksandar Rajkovic

doi:10.1055/s-0037-1599086

Seminars in Reproductive Medicine, Inhaltsverzeichnis

Semin Reprod Med 2017; 35(2): 147-159
DOI: 10.1055/s-0037-1599086

Review Article

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Genetics of Reproductive Aging from Gonadal Dysgenesis through Menopause

Swapna Desai

¹Department of Obstetrics, Gynecology, and Reproductive Sciences, Magee-Womens Research Institute, University of Pittsburgh, Pittsburgh, Pennsylvania

,

Aleksandar Rajkovic

¹Department of Obstetrics, Gynecology, and Reproductive Sciences, Magee-Womens Research Institute, University of Pittsburgh, Pittsburgh, Pennsylvania

²Department of Pathology, Magee-Womens Research Institute, University of Pittsburgh, Pittsburgh, Pennsylvania

³Department of Human Genetics, Magee-Womens Research Institute, University of Pittsburgh, Pittsburgh, Pennsylvania

› Institutsangaben

Abstract

Reproduction is essential for the survival of the species and is influenced by external factors such as smoking and exposure to chemotherapy as well as chronic disorders such as obesity and autoimmunity. Reproductive senescence, such as menopause, is also dependent on multiple intrinsic genetic factors. Reproductive aging is not isolated from an overall aging process, and several studies strongly support the link between the early age of menopause and mortality. The extreme form of reproductive aging is primary ovarian insufficiency (POI) with prevalence ranging from 1 to 5% of the female population. POI has been shown to have long-term consequences on overall health. POI and age of menopause have a significant hereditary component. The population-based genome-wide association studies have identified 44 genomic loci to associate with age of menopause, and 29 of 44 loci harbor DNA damage response genes. Recent application of whole exome sequencing on carefully selected families with POI has also revealed a significant contribution of DNA damage response genes. The inability to repair the DNA damage in both somatic and germ cells might be a predisposing factor for the link between reproductive and overall aging in a subset of individuals with POI. The aim of this review is to characterize recent advances in the genetics of POI and its link with overall health.

Keywords

ovarian reserve - menopause - primary ovarian insufficiency - DNA damage response genes

Volltext

Referenzen

References
1 Melby MK, Lock M, Kaufert P. Culture and symptom reporting at menopause. Hum Reprod Update 2005; 11 (5) 495-512
2 Nelson LM. Clinical practice. Primary ovarian insufficiency. N Engl J Med 2009; 360 (6) 606-614
3 Albright FSP, Fraser R. A syndrome characterized by primary ovarian insufficiency and decreased stature. Am J Med Sci 1942; 204: 625-648
4 Bidet M, Bachelot A, Bissauge E , et al. Resumption of ovarian function and pregnancies in 358 patients with premature ovarian failure. J Clin Endocrinol Metab 2011; 96 (12) 3864-3872
5 Sassarini J, Lumsden MA, Critchley HO. Sex hormone replacement in ovarian failure - new treatment concepts. Best Pract Res Clin Endocrinol Metab 2015; 29 (1) 105-114
6 Mitchell A, Fantasia HC. Understanding the effect of obesity on fertility among reproductive-age women. Nurs Womens Health 2016; 20 (4) 368-376
7 Oktay K, Kim JY, Barad D, Babayev SN. Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast/ovarian cancer risks. J Clin Oncol 2010; 28 (2) 240-244
8 Brand JS, van der Schouw YT, Onland-Moret NC , et al; InterAct Consortium. Age at menopause, reproductive life span, and type 2 diabetes risk: results from the EPIC-InterAct study. Diabetes Care 2013; 36 (4) 1012-1019
9 Levine ME, Lu AT, Chen BH , et al. Menopause accelerates biological aging. Proc Natl Acad Sci U S A 2016; 113 (33) 9327-9332
10 Mukerjee G, Dorfman R. High genetic heterogeneity of premature ovarian insufficiency from DNA replication and repair to hormonal regulation. J IHP 2014; 59-63
11 Kodaman PH. Early menopause: primary ovarian insufficiency and surgical menopause. Semin Reprod Med 2010; 28 (5) 360-369
12 Simpson JL, Rajkovic A. Ovarian differentiation and gonadal failure. Am J Med Genet 1999; 89 (4) 186-200
13 Devi A, Benn PA. X-chromosome abnormalities in women with premature ovarian failure. J Reprod Med 1999; 44 (4) 321-324
14 Pastore LM, Manichaikul A, Wang XQ, Finkelstein JS. FMR1 CGG repeats: reference levels and race-ethnic variation in women with normal fertility (Study of Women's Health Across the Nation). Reprod Sci 2016; 23 (9) 1225-1233
15 Murray A, Schoemaker MJ, Bennett CE , et al. Population-based estimates of the prevalence of FMR1 expansion mutations in women with early menopause and primary ovarian insufficiency. Genet Med 2014; 16 (1) 19-24
16 American College of Obstetricians and Gynecologists Committee on Genetics. ACOG committee opinion. No. 338: Screening for fragile X syndrome. Obstet Gynecol 2006; 107 (6) 1483-1485
17 De Vos M, Devroey P, Fauser BC. Primary ovarian insufficiency. Lancet 2010; 376 (9744): 911-921
18 Mendez P, Wandosell F, Garcia-Segura LM. Cross-talk between estrogen receptors and insulin-like growth factor-I receptor in the brain: cellular and molecular mechanisms. Front Neuroendocrinol 2006; 27 (4) 391-403
19 Yang JJ, Cho LY, Lim YJ , et al. Estrogen receptor-1 genetic polymorphisms for the risk of premature ovarian failure and early menopause. J Womens Health (Larchmt) 2010; 19 (2) 297-304
20 Rebar RW. Premature ovarian failure. Obstet Gynecol 2009; 113 (6) 1355-1363
21 Silva CA, Yamakami LY, Aikawa NE, Araujo DB, Carvalho JF, Bonfá E. Autoimmune primary ovarian insufficiency. Autoimmun Rev 2014; 13 (4-5): 427-430
22 Jin M, Yu Y, Huang H. An update on primary ovarian insufficiency. Sci China Life Sci 2012; 55 (8) 677-686
23 van Erven B, Gubbels CS, van Golde RJ , et al. Fertility preservation in female classic galactosemia patients. Orphanet J Rare Dis 2013; 8: 107
24 Davis M, Ventura JL, Wieners M , et al. The psychosocial transition associated with spontaneous 46,XX primary ovarian insufficiency: illness uncertainty, stigma, goal flexibility, and purpose in life as factors in emotional health. Fertil Steril 2010; 93 (7) 2321-2329
25 Richards M, Kuh D, Hardy R, Wadsworth M. Lifetime cognitive function and timing of the natural menopause. Neurology 1999; 53 (2) 308-314
26 van Asselt KM, Kok HS, Pearson PL , et al. Heritability of menopausal age in mothers and daughters. Fertil Steril 2004; 82 (5) 1348-1351
27 Murabito JM, Yang Q, Fox C, Wilson PW, Cupples LA. Heritability of age at natural menopause in the Framingham Heart Study. J Clin Endocrinol Metab 2005; 90 (6) 3427-3430
28 Opitz O, Zoll B, Hansmann I, Hinney B. Cytogenic investigation of 103 patients with primary or secondary amenorrhea. Hum Genet 1983; 65 (1) 46-47
29 van Kasteren YM, Hundscheid RD, Smits AP, Cremers FP, van Zonneveld P, Braat DD. Familial idiopathic premature ovarian failure: an overrated and underestimated genetic disease?. Hum Reprod 1999; 14 (10) 2455-2459
30 Wood MA, Rajkovic A. Genomic markers of ovarian reserve. Semin Reprod Med 2013; 31 (6) 399-415
31 Matzuk MM, Lamb DJ. Genetic dissection of mammalian fertility pathways. Nat Cell Biol 2002; 4 (Suppl) s41-s49
32 Bouilly J, Beau I, Barraud S , et al. Identification of multiple gene mutations accounts for a new genetic architecture of primary ovarian insufficiency. J Clin Endocrinol Metab 2016; 101 (12) 4541-4550
33 Soyal SM, Amleh A, Dean J. FIGalpha, a germ cell-specific transcription factor required for ovarian follicle formation. Development 2000; 127 (21) 4645-4654
34 Pangas SA, Choi Y, Ballow DJ , et al. Oogenesis requires germ cell-specific transcriptional regulators Sohlh1 and Lhx8. Proc Natl Acad Sci U S A 2006; 103 (21) 8090-8095
35 Rajkovic A, Pangas SA, Ballow D, Suzumori N, Matzuk MM. NOBOX deficiency disrupts early folliculogenesis and oocyte-specific gene expression. Science 2004; 305 (5687): 1157-1159
36 Dong J, Albertini DF, Nishimori K, Kumar TR, Lu N, Matzuk MM. Growth differentiation factor-9 is required during early ovarian folliculogenesis. Nature 1996; 383 (6600): 531-535
37 John GB, Shirley LJ, Gallardo TD, Castrillon DH. Specificity of the requirement for Foxo3 in primordial follicle activation. Reproduction 2007; 133 (5) 855-863
38 Castrillon DH, Miao L, Kollipara R, Horner JW, DePinho RA. Suppression of ovarian follicle activation in mice by the transcription factor Foxo3a. Science 2003; 301 (5630): 215-218
39 Alvarez B, Martínez-A C, Burgering BM, Carrera AC. Forkhead transcription factors contribute to execution of the mitotic programme in mammals. Nature 2001; 413 (6857): 744-747
40 Li J, Kawamura K, Cheng Y , et al. Activation of dormant ovarian follicles to generate mature eggs. Proc Natl Acad Sci U S A 2010; 107 (22) 10280-10284
41 Zhang H, Risal S, Gorre N , et al. Somatic cells initiate primordial follicle activation and govern the development of dormant oocytes in mice. Curr Biol 2014; 24 (21) 2501-2508
42 Zhang H, Liu K. Cellular and molecular regulation of the activation of mammalian primordial follicles: somatic cells initiate follicle activation in adulthood. Hum Reprod Update 2015; 21 (6) 779-786
43 Laissue P, Lakhal B, Benayoun BA , et al. Functional evidence implicating FOXL2 in non-syndromic premature ovarian failure and in the regulation of the transcription factor OSR2. J Med Genet 2009; 46 (7) 455-457
44 Zhao H, Chen ZJ, Qin Y , et al. Transcription factor FIGLA is mutated in patients with premature ovarian failure. Am J Hum Genet 2008; 82 (6) 1342-1348
45 Tosh D, Rani HS, Murty US, Deenadayal A, Grover P. Mutational analysis of the FIGLA gene in women with idiopathic premature ovarian failure. Menopause 2015; 22 (5) 520-526
46 Bayram Y, Gulsuner S, Guran T , et al. Homozygous loss-of-function mutations in SOHLH1 in patients with nonsyndromic hypergonadotropic hypogonadism. J Clin Endocrinol Metab 2015; 100 (5) E808-E814
47 Lourenço D, Brauner R, Lin L , et al. Mutations in NR5A1 associated with ovarian insufficiency. N Engl J Med 2009; 360 (12) 1200-1210
48 Persani L, Rossetti R, Di Pasquale E, Cacciatore C, Fabre S. The fundamental role of bone morphogenetic protein 15 in ovarian function and its involvement in female fertility disorders. Hum Reprod Update 2014; 20 (6) 869-883
49 Bouilly J, Roucher-Boulez F, Gompel A , et al. New NOBOX mutations identified in a large cohort of women with primary ovarian insufficiency decrease KIT-L expression. J Clin Endocrinol Metab 2015; 100 (3) 994-1001
50 Bouilly J, Bachelot A, Broutin I, Touraine P, Binart N. Novel NOBOX loss-of-function mutations account for 6.2% of cases in a large primary ovarian insufficiency cohort. Hum Mutat 2011; 32 (10) 1108-1113
51 Chatterjee S, Modi D, Maitra A , et al. Screening for FOXL2 gene mutations in women with premature ovarian failure: an Indian experience. Reprod Biomed Online 2007; 15 (5) 554-560
52 Zhao H, Qin Y, Kovanci E, Simpson JL, Chen ZJ, Rajkovic A. Analyses of GDF9 mutation in 100 Chinese women with premature ovarian failure. Fertil Steril 2007; 88 (5) 1474-1476
53 Calderon FR, Phansalkar AR, Crockett DK, Miller M, Mao R. Mutation database for the galactose-1-phosphate uridyltransferase (GALT) gene. Hum Mutat 2007; 28 (10) 939-943
54 Di Pasquale E, Beck-Peccoz P, Persani L. Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (BMP15) gene. Am J Hum Genet 2004; 75 (1) 106-111
55 Kosaki K, Sato S, Hasegawa T, Matsuo N, Suzuki T, Ogata T. Premature ovarian failure in a female with proximal symphalangism and Noggin mutation. Fertil Steril 2004; 81 (4) 1137-1139
56 Demirhan O, Türkmen S, Schwabe GC , et al. A homozygous BMPR1B mutation causes a new subtype of acromesomelic chondrodysplasia with genital anomalies. J Med Genet 2005; 42 (4) 314-317
57 McPherson E, Turner L, Zador I, Reynolds K, Macgregor D, Giampietro PF. Ovarian failure and dilated cardiomyopathy due to a novel lamin mutation. Am J Med Genet A 2009; 149A (4) 567-572
58 Wang H, Li G, Zhang J , et al. Novel WT1 missense mutations in Han Chinese women with premature ovarian failure. Sci Rep 2015; 5: 13983
59 Santos MG, Machado AZ, Martins CN , et al. Homozygous inactivating mutation in NANOS3 in two sisters with primary ovarian insufficiency. BioMed Res Int 2014; 2014: 787465
60 Mansouri MR, Schuster J, Badhai J , et al. Alterations in the expression, structure and function of progesterone receptor membrane component-1 (PGRMC1) in premature ovarian failure. Hum Mol Genet 2008; 17 (23) 3776-3783
61 Coppieters F, Ascari G, Dannhausen K , et al. Isolated and syndromic retinal dystrophy caused by biallelic mutations in RCBTB1, a gene implicated in ubiquitination. Am J Hum Genet 2016; 99 (2) 470-480
62 Kumar TR, Wang Y, Lu N, Matzuk MM. Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility. Nat Genet 1997; 15 (2) 201-204
63 Dierich A, Sairam MR, Monaco L , et al. Impairing follicle-stimulating hormone (FSH) signaling in vivo: targeted disruption of the FSH receptor leads to aberrant gametogenesis and hormonal imbalance. Proc Natl Acad Sci U S A 1998; 95 (23) 13612-13617
64 Matthews CH, Borgato S, Beck-Peccoz P , et al. Primary amenorrhoea and infertility due to a mutation in the beta-subunit of follicle-stimulating hormone. Nat Genet 1993; 5 (1) 83-86
65 Aittomäki K, Lucena JL, Pakarinen P , et al. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell 1995; 82 (6) 959-968
66 Desai SS, Roy BS, Mahale SD. Mutations and polymorphisms in FSH receptor: functional implications in human reproduction. Reproduction 2013; 146 (6) R235-R248
67 Bose HS, Pescovitz OH, Miller WL. Spontaneous feminization in a 46,XX female patient with congenital lipoid adrenal hyperplasia due to a homozygous frameshift mutation in the steroidogenic acute regulatory protein. J Clin Endocrinol Metab 1997; 82 (5) 1511-1515
68 Conte FA, Grumbach MM, Ito Y, Fisher CR, Simpson ER. A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom). J Clin Endocrinol Metab 1994; 78 (6) 1287-1292
69 Pikó L, Taylor KD. Amounts of mitochondrial DNA and abundance of some mitochondrial gene transcripts in early mouse embryos. Dev Biol 1987; 123 (2) 364-374
70 Shoubridge EA, Wai T. Mitochondrial DNA and the mammalian oocyte. Curr Top Dev Biol 2007; 77: 87-111
71 Bonomi M, Somigliana E, Cacciatore C , et al; Italian Network for the study of Ovarian Dysfunctions. Blood cell mitochondrial DNA content and premature ovarian aging. PLoS One 2012; 7 (8) e42423
72 Pagnamenta AT, Taanman JW, Wilson CJ , et al. Dominant inheritance of premature ovarian failure associated with mutant mitochondrial DNA polymerase gamma. Hum Reprod 2006; 21 (10) 2467-2473
73 Pierce SB, Chisholm KM, Lynch ED , et al. Mutations in mitochondrial histidyl tRNA synthetase HARS2 cause ovarian dysgenesis and sensorineural hearing loss of Perrault syndrome. Proc Natl Acad Sci U S A 2011; 108 (16) 6543-6548
74 Matthijs G, Schollen E, Pardon E , et al. Mutations in PMM2, a phosphomannomutase gene on chromosome 16p13, in carbohydrate-deficient glycoprotein type I syndrome (Jaeken syndrome). Nat Genet 1997; 16 (1) 88-92
75 Cervato S, Mariniello B, Lazzarotto F , et al. Evaluation of the autoimmune regulator (AIRE) gene mutations in a cohort of Italian patients with autoimmune-polyendocrinopathy-candidiasis-ectodermal-dystrophy (APECED) and in their relatives. Clin Endocrinol (Oxf) 2009; 70 (3) 421-428
76 de Vries L, Behar DM, Smirin-Yosef P, Lagovsky I, Tzur S, Basel-Vanagaite L. Exome sequencing reveals SYCE1 mutation associated with autosomal recessive primary ovarian insufficiency. J Clin Endocrinol Metab 2014; 99 (10) E2129-E2132
77 Caburet S, Arboleda VA, Llano E , et al. Mutant cohesin in premature ovarian failure. N Engl J Med 2014; 370 (10) 943-949
78 Wang J, Zhang W, Jiang H, Wu BL ; Primary Ovarian Insufficiency Collaboration. Mutations in HFM1 in recessive primary ovarian insufficiency. N Engl J Med 2014; 370 (10) 972-974
79 AlAsiri S, Basit S, Wood-Trageser MA , et al. Exome sequencing reveals MCM8 mutation underlies ovarian failure and chromosomal instability. J Clin Invest 2015; 125 (1) 258-262
80 Tenenbaum-Rakover Y, Weinberg-Shukron A, Renbaum P , et al. Minichromosome maintenance complex component 8 (MCM8) gene mutations result in primary gonadal failure. J Med Genet 2015; 52 (6) 391-399
81 Wood-Trageser MA, Gurbuz F, Yatsenko SA , et al. MCM9 mutations are associated with ovarian failure, short stature, and chromosomal instability. Am J Hum Genet 2014; 95 (6) 754-762
82 Faridi R, Rehman AU, Morell RJ , et al. Mutations of SGO2 and CLDN14 collectively cause coincidental Perrault syndrome. Clin Genet 2016; 91 (2) 328-332
83 Zangen D, Kaufman Y, Zeligson S , et al. XX ovarian dysgenesis is caused by a PSMC3IP/HOP2 mutation that abolishes coactivation of estrogen-driven transcription. Am J Hum Genet 2011; 89 (4) 572-579
84 Weinberg-Shukron A, Renbaum P, Kalifa R , et al. A mutation in the nucleoporin-107 gene causes XX gonadal dysgenesis. J Clin Invest 2015; 125 (11) 4295-4304
85 Savitsky K, Bar-Shira A, Gilad S , et al. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 1995; 268 (5218): 1749-1753
86 Chrzanowska KH, Szarras-Czapnik M, Gajdulewicz M , et al. High prevalence of primary ovarian insufficiency in girls and young women with Nijmegen breakage syndrome: evidence from a longitudinal study. J Clin Endocrinol Metab 2010; 95 (7) 3133-3140
87 Arora H, Chacon AH, Choudhary S , et al. Bloom syndrome. Int J Dermatol 2014; 53 (7) 798-802
88 Rossi ML, Ghosh AK, Bohr VA. Roles of Werner syndrome protein in protection of genome integrity. DNA Repair (Amst) 2010; 9 (3) 331-344
89 Siitonen HA, Sotkasiira J, Biervliet M , et al. The mutation spectrum in RECQL4 diseases. Eur J Hum Genet 2009; 17 (2) 151-158
90 Giri N, Batista DL, Alter BP, Stratakis CA. Endocrine abnormalities in patients with Fanconi anemia. J Clin Endocrinol Metab 2007; 92 (7) 2624-2631
91 Alazami AM, Al-Saif A, Al-Semari A , et al. Mutations in C2orf37, encoding a nucleolar protein, cause hypogonadism, alopecia, diabetes mellitus, mental retardation, and extrapyramidal syndrome. Am J Hum Genet 2008; 83 (6) 684-691
92 Desai S, Wood-Trageser M, Matic J , et al. MCM8 and MCM9 nucleotide variants in women with primary ovarian insufficiency. J Clin Endocrinol Metab 2016; jc20162565
93 He C, Kraft P, Chen C , et al. Genome-wide association studies identify loci associated with age at menarche and age at natural menopause. Nat Genet 2009; 41 (6) 724-728
94 He C, Kraft P, Chasman DI , et al. A large-scale candidate gene association study of age at menarche and age at natural menopause. Hum Genet 2010; 128 (5) 515-527
95 Stolk L, Zhai G, van Meurs JB , et al. Loci at chromosomes 13, 19 and 20 influence age at natural menopause. Nat Genet 2009; 41 (6) 645-647
96 Spencer KL, Malinowski J, Carty CL , et al. Genetic variation and reproductive timing: African American women from the Population Architecture using Genomics and Epidemiology (PAGE) Study. PLoS One 2013; 8 (2) e55258
97 Day FR, Ruth KS, Thompson DJ , et al; PRACTICAL Consortium; kConFab Investigators; AOCS Investigators; Generation Scotland; EPIC-InterAct Consortium; LifeLines Cohort Study. Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair. Nat Genet 2015; 47 (11) 1294-1303
98 Chen CT, Fernández-Rhodes L, Brzyski RG , et al. Replication of loci influencing ages at menarche and menopause in Hispanic women: the Women's Health Initiative SHARe Study. Hum Mol Genet 2012; 21 (6) 1419-1432
99 Stolk L, Perry JR, Chasman DI , et al; LifeLines Cohort Study. Meta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathways. Nat Genet 2012; 44 (3) 260-268
100 Chen CT, Liu CT, Chen GK , et al. Meta-analysis of loci associated with age at natural menopause in African-American women. Hum Mol Genet 2014; 23 (12) 3327-3342
101 Murray A, Bennett CE, Perry JR , et al; ReproGen Consortium. Common genetic variants are significant risk factors for early menopause: results from the Breakthrough Generations Study. Hum Mol Genet 2011; 20 (1) 186-192
102 Lutzmann M, Grey C, Traver S , et al. MCM8- and MCM9-deficient mice reveal gametogenesis defects and genome instability due to impaired homologous recombination. Mol Cell 2012; 47 (4) 523-534
103 Wei K, Clark AB, Wong E , et al. Inactivation of Exonuclease 1 in mice results in DNA mismatch repair defects, increased cancer susceptibility, and male and female sterility. Genes Dev 2003; 17 (5) 603-614
104 Kang H, Lee SK, Kim MH , et al. Parathyroid hormone-responsive B1 gene is associated with premature ovarian failure. Hum Reprod 2008; 23 (6) 1457-1465
105 Knauff EA, Franke L, van Es MA , et al; Dutch POF Consortium. Genome-wide association study in premature ovarian failure patients suggests ADAMTS19 as a possible candidate gene. Hum Reprod 2009; 24 (9) 2372-2378
106 Qin Y, Sun M, You L , et al. ESR1, HK3 and BRSK1 gene variants are associated with both age at natural menopause and premature ovarian failure. Orphanet J Rare Dis 2012; 7: 5
107 Perry JR, Corre T, Esko T , et al; ReproGen Consortium. A genome-wide association study of early menopause and the combined impact of identified variants. Hum Mol Genet 2013; 22 (7) 1465-1472
108 Kannel WB. Metabolic risk factors for coronary heart disease in women: perspective from the Framingham Study. Am Heart J 1987; 114 (2) 413-419
109 Shuster LT, Rhodes DJ, Gostout BS, Grossardt BR, Rocca WA. Premature menopause or early menopause: long-term health consequences. Maturitas 2010; 65 (2) 161-166
110 Løkkegaard E, Jovanovic Z, Heitmann BL, Keiding N, Ottesen B, Pedersen AT. The association between early menopause and risk of ischaemic heart disease: influence of hormone therapy. Maturitas 2006; 53 (2) 226-233
111 Parker WH, Jacoby V, Shoupe D, Rocca W. Effect of bilateral oophorectomy on women's long-term health. Womens Health (Lond) 2009; 5 (5) 565-576
112 Kok HS, van Asselt KM, van der Schouw YT , et al. Heart disease risk determines menopausal age rather than the reverse. J Am Coll Cardiol 2006; 47 (10) 1976-1983
113 Schoemaker MJ, Swerdlow AJ, Higgins CD, Wright AF, Jacobs PA ; United Kingdom Clinical Cytogenetics Group. Mortality in women with turner syndrome in Great Britain: a national cohort study. J Clin Endocrinol Metab 2008; 93 (12) 4735-4742
114 Cedars MI. Biomarkers of ovarian reserve--do they predict somatic aging?. Semin Reprod Med 2013; 31 (6) 443-451
115 Cooley M, Bakalov V, Bondy CA. Lipid profiles in women with 45,X vs 46,XX primary ovarian failure. JAMA 2003; 290 (16) 2127-2128
116 Ewertz M, Mellemkjaer L, Poulsen AH , et al. Hormone use for menopausal symptoms and risk of breast cancer. A Danish cohort study. Br J Cancer 2005; 92 (7) 1293-1297
117 Giordano S, Garrett-Mayer E, Mittal N , et al. Association of BRCA1 mutations with impaired ovarian reserve: connection between infertility and breast/ovarian cancer risk. J Adolesc Young Adult Oncol 2016; 5 (4) 337-343
118 Finch A, Valentini A, Greenblatt E , et al; Hereditary Breast Cancer Study Group. Frequency of premature menopause in women who carry a BRCA1 or BRCA2 mutation. Fertil Steril 2013; 99 (6) 1724-1728
119 Lin WT, Beattie M, Chen LM , et al. Comparison of age at natural menopause in BRCA1/2 mutation carriers with a non-clinic-based sample of women in northern California. Cancer 2013; 119 (9) 1652-1659
120 Yeshaya A, Orvieto R, Dicker D, Karp M, Ben-Rafael Z. Menstrual characteristics of women suffering from insulin-dependent diabetes mellitus. Int J Fertil Menopausal Stud 1995; 40 (5) 269-273
121 Dorman JS, Steenkiste AR, Foley TP , et al; Familial Autoimmune and Diabetes (FAD) Study. Menopause in type 1 diabetic women: is it premature?. Diabetes 2001; 50 (8) 1857-1862
122 Isik S, Ozcan HN, Ozuguz U , et al. Evaluation of ovarian reserve based on hormonal parameters, ovarian volume, and antral follicle count in women with type 2 diabetes mellitus. J Clin Endocrinol Metab 2012; 97 (1) 261-269